Hypokalemia Market Competitive Industry Scenario till 2030
The global Hypokalemia Market is anticipated to experience steady revenue growth throughout the forecast period, primarily due to the increasing prevalence of hyperkalemia. Hyperkalemia is a disorder characterized by elevated levels of potassium in the blood. The National Kidney Foundation reports that approximately 2 to 3% of the global population is affected by hyperkalemia. Certain factors contribute to the development of hyperkalemia, including chronic kidney disease, heart failure, diabetes mellitus, and the use of ACE inhibitors and beta-blockers. Patients with chronic kidney disease have a 40-50% chance of developing hyperkalemia, while diabetes patients and heart failure patients have a 36% and 21% chance, respectively. The growing awareness of the severity of hyperkalemia, expanded treatment options, and improved accessibility and affordability of healthcare services are driving the revenue growth of the market. Hyperkalemia is a life-threatening condition that requires urg...